Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging
Authors not listed
University of Pennsylvania · 2017
Abstract
The purpose of this study is to measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). 18F-AV-1451 is a specialized radioactive PET imaging agent that is able to detect the presence of tau in the brain. In this study, the investigator will use the 18F-AV-1451 to capture images of tau in the brain. Findings from this study will likely provide insight into the mechanisms and distinctions of age-related cognitive decline and that of very early Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Anonymous. (2017). Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging. <em>University of Pennsylvania</em>. https://clinicaltrials.gov/study/NCT03189485
Vancouver
Anonymous. Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging. University of Pennsylvania. 2017.
BibTeX
@misc{anon2017TauPET,
title = {Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging},
author = {Anonymous},
journal = {University of Pennsylvania},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Colorado, Denver 2016
Open access · US-GOV
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
Amsterdam UMC, location VUmc 2001
Open access · US-GOV
The Distribution and Quantification of Specific Binding of the Positron Emission Tomography Tracer R)-[11C]PK11195 in Normal Human Subjects
Acta Neuropathologica 2003
Citation only
α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study
William Charles Kreisl 2016
Open access · US-GOV
Imaging Tau in Alzheimer's Disease and Normal Aging
Patrick Lao 2017
Open access · US-GOV
Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240
Communications Medicine 2025
Open access · CC-BY